— Know what they know.
Not Investment Advice
Also trades as: GBM.F (FSX) · $vol 0M · GBMB.F (FSX) · $vol 0M

INO NASDAQ

Inovio Pharmaceuticals, Inc.
1W: -11.9% 1M: -23.9% 3M: -14.4% YTD: -47.3% 1Y: -61.8% 3Y: -84.2% 5Y: -99.0%
$0.89
+0.02 (+2.32%)
 
Weekly Expected Move ±15.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 26 · $61.5M mcap · 82M float · 4.45% daily turnover · Short 31% of daily vol
Credit Risk of going bust: higher than 80% of companies Debt: 11.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 98%), Inovio Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $8.0M against a stock market value of $61.5M.
Distance to default 2.60 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.0M (short-term plus half of long-term), stock volatility 98.2%; Altman Z'' -130.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
26.5 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 257.7%
Cost Advantage
23
Intangibles
25
Switching Cost
23
Network Effect
39
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. INO has No discernible competitive edge (26.5/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 257.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$3
Low
$3
Avg Target
$3
High
Based on 1 analyst since Aug 12, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 5Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$3.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-13 Jefferies — Initiated $3 — +233.4% $0.90
2026-06-01 H.C. Wainwright — Initiated $2 — +90.8% $1.31
2025-11-14 Piper Sandler Edward Tenthoff Initiated $6 — +201.5% $1.99
2024-08-09 RBC Capital Gregory Renza Initiated $8 — -8.2% $8.71
2024-05-14 Oppenheimer Hartaj Singh $4 $40 +36 +249.5% $11.45
2024-05-13 Stephens Sudan Loganathan Initiated $20 — +76.1% $11.36
2024-01-25 Oppenheimer Hartaj Singh Initiated $4 — -41.1% $6.79

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
Oct 27, 2026
DCF
4
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. INO receives an overall rating of C-. Strongest factors: DCF (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-14 C+ C-
2026-08-13 C- C+
2026-05-20 C+ C-
2026-05-14 C C+
2026-05-13 C- C
2026-05-04 D+ C-
2026-04-27 C- D+
2026-03-18 C+ C-
2026-03-13 C C+
2026-03-12 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
56
Earnings Quality
30
Growth
46
Value
15
Momentum
49
Safety
0
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-55.49
Distress Zone
Piotroski F-Score
1/9
✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
3.77
Bankruptcy prob: 97.7%
High Risk
Credit Rating
B
Score: 27.6/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 1.20x
Accruals: 22.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. INO scores -55.49, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. INO scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. INO's implied 97.7% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. INO receives an estimated rating of B (score: 27.6/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.76x
PEG
-0.00x
P/S
0.00x
P/B
16.62x
P/FCF
-1.11x
P/OCF
—
EV/EBITDA
-0.95x
EV/Revenue
—
EV/EBIT
-0.91x
EV/FCF
-0.76x
Earnings Yield
-75.10%
FCF Yield
-89.97%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. INO currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
3.575
Assets / Equity
=
ROE
-409.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. INO's ROE of -409.9% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.89
Median 1Y
$0.32
5th Pctile
$0.06
95th Pctile
$1.70
Ann. Volatility
105.4%
Analyst Target
$3.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jacqueline E. Shea,
Ph.D. President and Chief Executive Officer
$728,000 $346,101 $1,587,155
Michael Sumner, M.D.
Chief Medical Officer and Head of Development
$548,708 $127,607 $910,636
Peter D. Kies
Chief Financial Officer
$514,604 $117,479 $833,684

CEO Pay Ratio

5:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,587,155
Avg Employee Cost (SGA/emp): $291,791
Employees: 112

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
112
-16.4% YoY
Revenue / Employee
$583
Rev: $65,343
Profit / Employee
$-758,446
NI: $-84,945,901
SGA / Employee
$291,791
Avg labor cost proxy
R&D / Employee
$483,990
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -56.9% -70.6% -70.1% -88.0% -92.3% -90.0% -87.1% -72.1% -81.3% -79.5% -85.1% -91.4% -1.1% -1.2% -1.3% -1.4% -3.3% -1.8% -3.0% -4.1% -4.10%
ROA -45.4% -58.6% -59.7% -67.5% -71.6% -66.3% -67.8% -48.6% -56.3% -52.0% -63.1% -66.3% -75.2% -75.5% -89.2% -86.9% -1.2% -90.6% -1.2% -1.1% -1.15%
ROIC -1.9% -7.6% -8.9% 15.7% -14.5% -147.0% -28.6% -26.2% -279.8% -50.2% -46.1% 143.6% -79.9% 6.5% 14.3% 9.1% 1.5% 2.7% 2.9% 2.6% 2.58%
ROCE -44.6% -70.0% -84.0% -1.1% -1.1% -1.1% -1.1% -92.3% -1.1% -1.0% -1.2% -1.1% -1.3% -1.4% -1.6% -2.4% 246.7% -2.8% -7.2% -7.1% -7.12%
Gross Margin 1.0% -64.4% 1.0% 1.0% 1.0% -9.8% -9.0% 1.0% 1.0% -70.7% — -7.2% — -5.6% 1.0% — — — — — —
Operating Margin -205.5% -125.7% -360.3% -132.8% -3.9% -448.8% -382.4% -163.9% -91.5% -266.9% — -329.5% — -174.1% -383.4% — — — — — —
Net Margin -206.3% -127.5% -397.2% -138.3% -4.1% -436.9% -353.6% -157.3% -87.3% -243.6% — -319.9% — -165.7% -301.4% — — — — — —
EBITDA Margin -200.7% -125.2% -377.8% -136.1% -3.9% -423.5% -340.9% -150.8% -83.9% -239.1% — -311.7% — -159.0% -290.0% — — — — — —
FCF Margin -35.4% -122.2% -139.6% -92.9% -19.8% -21.0% -18.9% -18.0% -158.0% -149.5% -162.0% -190.1% -545.0% -480.2% -362.8% -114542.9% -114511.0% -319535.9% — — —
OCF Margin -35.1% -121.5% -140.2% -93.1% -19.8% -21.1% -18.8% -18.0% -157.4% -149.5% -162.4% -189.8% -544.2% -478.0% -361.0% -114542.5% -114510.3% -319532.0% — — —
ROE 3Y Avg snapshot only -6.59%
ROE 5Y Avg snapshot only -4.39%
ROA 3Y Avg snapshot only -1.19%
ROIC Economic snapshot only -5.06%
Cash ROA snapshot only -1.63%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -81.74 -41.47 -28.73 -13.77 -15.58 -1.43 -0.88 -0.71 -0.64 -1.03 -2.59 -1.81 -1.44 -0.46 -0.46 -0.90 -1.13 -9.60 -1.42 -1.33 -0.764
P/S Ratio 2772.99 7095.65 5885.01 2310.18 471.59 39.02 20.82 12.37 122.67 167.66 450.84 371.30 799.61 228.26 156.38 434.43 669.50 12485.24 — — 0.000
P/B Ratio 39.84 31.51 26.56 16.41 19.41 1.80 1.06 0.70 0.76 1.19 3.42 2.27 2.21 0.73 0.86 2.78 -15.81 33.86 19.82 20.54 16.619
P/FCF -78.36 -58.05 -42.16 -24.88 -23.83 -1.86 -1.10 -0.69 -0.78 -1.12 -2.78 -1.95 -1.47 -0.48 -0.43 -0.00 -0.01 -0.04 -0.01 -1.11 -1.111
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -83.95 -41.22 -28.51 -13.22 -15.25 -0.66 -0.08 0.28 0.21 -0.19 -1.91 -1.04 -0.82 0.31 0.14 -0.50 -0.77 -9.35 -1.11 -0.95 -0.949
EV/Revenue 2717.46 6888.13 5681.14 2161.28 448.87 17.49 1.90 -4.70 -38.53 29.34 322.28 206.67 443.89 -149.45 -45.28 232.11 445.84 11733.14 — — —
EV/EBIT -81.92 -40.58 -28.07 -13.02 -14.99 -0.65 -0.08 0.27 0.20 -0.18 -1.87 -1.01 -0.80 0.30 0.13 -0.48 -0.75 -9.03 -1.07 -0.91 -0.906
EV/FCF -76.79 -56.35 -40.69 -23.28 -22.68 -0.83 -0.10 0.26 0.24 -0.20 -1.99 -1.09 -0.81 0.31 0.12 -0.00 -0.00 -0.04 -0.00 -0.76 -0.757
Earnings Yield -1.2% -2.4% -3.5% -7.3% -6.4% -69.9% -1.1% -1.4% -1.6% -96.9% -38.6% -55.4% -69.4% -2.2% -2.2% -1.1% -88.5% -10.4% -70.6% -75.1% -75.10%
FCF Yield -1.3% -1.7% -2.4% -4.0% -4.2% -53.7% -90.7% -1.5% -1.3% -89.2% -35.9% -51.2% -68.2% -2.1% -2.3% -263.7% -171.0% -25.6% -173.6% -90.0% -89.97%
Price/Tangible Book snapshot only 20.540
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 9.49 6.82 6.74 3.18 3.69 3.25 4.24 3.91 4.00 3.60 4.77 4.45 3.88 2.77 2.63 1.66 0.79 1.40 1.04 1.00 1.000
Quick Ratio 9.49 6.82 6.74 3.18 3.69 3.25 4.24 3.91 4.00 3.60 4.77 4.45 3.88 2.77 2.63 1.66 0.79 1.40 1.04 1.00 1.000
Debt/Equity 0.07 0.08 0.09 0.11 0.12 0.14 0.16 0.18 0.22 0.26 0.14 0.13 0.17 0.17 0.22 0.37 -1.30 0.39 1.43 1.83 1.831
Net Debt/Equity -0.80 -0.92 -0.92 -1.06 -0.94 -0.99 -0.97 -0.97 -1.00 -0.98 -0.98 -1.01 -0.98 -1.20 -1.11 -1.29 — -2.04 -4.78 -6.56 -6.559
Debt/Assets 0.06 0.07 0.08 0.07 0.08 0.09 0.12 0.13 0.15 0.18 0.10 0.10 0.12 0.10 0.13 0.16 0.14 0.13 0.17 0.16 0.162
Debt/EBITDA -0.16 -0.11 -0.11 -0.10 -0.10 -0.12 -0.13 -0.19 -0.19 -0.23 -0.11 -0.11 -0.11 -0.11 -0.12 -0.13 -0.10 -0.11 -0.11 -0.12 -0.124
Net Debt/EBITDA 1.72 1.24 1.02 0.91 0.77 0.82 0.82 1.01 0.87 0.88 0.76 0.83 0.66 0.79 0.61 0.44 0.39 0.60 0.35 0.45 0.445
Interest Coverage -85.64 -155.59 -186.79 -221.60 -231.36 -220.42 -191.51 -133.32 -130.25 -109.50 -113.92 -156.23 -244.30 -602.12 — — — — — — —
Equity Multiplier 1.18 1.24 1.25 1.54 1.47 1.57 1.34 1.38 1.40 1.46 1.37 1.38 1.46 1.65 1.70 2.39 -8.99 3.08 8.20 11.30 11.299
Cash Ratio snapshot only 0.919
Cash to Debt snapshot only 4.583
FCF to Debt snapshot only -10.095
Defensive Interval snapshot only 172.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.01 0.00 0.00 0.00 0.02 0.02 0.03 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 1.05 0.15 0.23 0.24 3.04 2.86 4.99 4.29 0.37 0.41 0.55 0.67 0.10 0.12 0.15 0.14 0.13 0.11 0.00 0.00 0.000
Payables Turnover 0.98 0.09 0.04 0.04 0.06 0.05 0.10 0.10 0.28 0.10 0.02 0.12 0.22 0.29 0.23 0.26 0.27 0.33 0.60 0.18 0.175
DSO 349 2471 1585 1520 120 127 73 85 980 901 668 549 3595 3021 2489 2616 2844 3350 — — —
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 371 3896 8769 9454 5745 6639 3805 3644 1326 3538 21777 3048 1689 1262 1572 1430 1358 1106 612 2086 2085.6 days
Cash Conversion Cycle -22 -1425 -7184 -7934 -5625 -6512 -3732 -3559 -346 -2637 -21109 -2499 1906 1759 917 1186 1486 2244 — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 2.1% -76.1% -75.2% -67.3% 68.5% 4.8% 5.4% 3.5% -92.2% -91.9% -93.0% -93.8% -76.2% -73.8% -60.5% -69.2% -10.4% -70.0% -1.0% -1.0% -1.00%
Net Income -23.0% -82.5% -74.4% -1.5% -50.3% 7.9% 26.5% 52.5% 50.5% 51.7% 48.2% 27.8% 31.4% 20.6% 22.8% 27.9% 4.2% 20.8% 12.0% 23.2% 23.17%
EPS -2.0% -43.5% -61.2% -1.2% -26.8% -8.1% -6.5% -4.1% -4.5% 54.7% 52.1% 41.5% 45.4% 33.4% 33.8% 49.5% 48.3% 95.4% 65.4% 63.4% 63.45%
FCF -63.3% -20.9% -8.1% 24.0% 5.8% 0.8% 14.1% 11.7% 37.9% 42.2% 39.6% 35.1% 17.8% 15.9% 11.6% -184.6% -187.3% -198.7% -202.2% 99.6% 99.61%
EBITDA -29.3% -99.0% -85.4% -1.7% -53.2% 8.7% 26.5% 53.1% 50.9% 51.9% 48.6% 27.2% 30.7% 20.3% 22.7% 28.2% 4.4% 21.2% 12.2% 24.0% 23.98%
Op. Income -79.8% -1.4% -1.1% -69.5% -40.9% 11.2% 25.2% 49.4% 45.6% 46.2% 45.2% 26.1% 30.8% 21.9% 19.4% 24.9% 24.9% 22.8% 21.0% 17.3% 17.31%
OCF Growth snapshot only 99.61%
Asset Growth snapshot only -27.62%
Equity Growth snapshot only -84.68%
Debt Growth snapshot only -24.92%
Shares Change snapshot only 1.10%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -43.8% -61.2% -63.1% -34.3% 20.1% 35.6% 57.4% 52.0% -26.0% -51.8% -51.9% -54.9% -68.5% -50.3% -43.9% -55.8% -74.5% -81.5% — — —
Revenue 5Y -27.6% -45.0% -46.8% -47.3% -23.5% -24.6% -21.1% -23.8% -52.9% -51.3% -53.2% -39.8% -49.7% -44.4% -35.9% -41.8% -38.7% -61.2% — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 56.2% 55.8% 32.6% 40.7% 37.3% 34.3% -7.7% -19.3% -23.9% -31.8% -41.8% -39.1% -41.5% -38.9% -41.9% -47.0% -43.9% -40.3% -42.8% -40.4% -40.38%
Assets 5Y 22.5% 23.3% 23.8% 23.7% 14.0% 13.2% 8.9% 9.4% 6.5% 5.4% -7.5% -4.1% -6.7% -4.7% -23.8% -31.2% -30.8% -32.7% -40.3% -39.1% -39.15%
Equity 3Y 63.6% 66.3% 65.8% 77.1% 99.3% 3.0% 2.6% -3.1% -24.7% -36.6% -45.4% -42.5% -45.5% -44.5% -47.5% -54.2% — -52.3% -68.8% -70.4% -70.45%
Book Value 3Y 24.4% 28.7% 26.6% 32.3% 48.3% 6.2% 84.2% 86.0% 49.2% 22.7% 12.2% 13.6% 6.6% 9.9% 5.2% -16.6% — -83.0% -78.8% -80.9% -80.90%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.66 0.81 0.80 0.72 0.53 0.56 0.49 0.52 0.61 0.69 0.67 0.19 0.31 0.09 0.03 0.05 0.15 0.60 0.53 0.56 0.562
Earnings Stability 0.88 0.77 0.74 0.69 0.88 0.85 0.73 0.32 0.44 0.25 0.15 0.00 0.00 0.01 0.06 0.26 0.30 0.45 0.56 0.40 0.397
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.91 0.50 0.50 0.50 0.50 0.97 0.89 0.50 0.50 0.50 0.81 0.89 0.87 0.92 0.91 0.89 0.98 0.92 0.95 0.91 0.907
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 1.49 16.79 -0.43 -0.46 -0.72 -0.70 -0.59 -0.26 -0.32 -0.14 -0.25 -0.16 -0.32 -0.36 -0.62 -1.95 — -2.17 -12.39 -13.26 -13.259
Gross Margin Trend 13.32 12.98 14.74 12.62 11.96 3.54 3.96 2.10 -0.85 -1.14 0.31 -1.24 -3.41 -6.50 -5.42 -7.34 -4.39 -18.41 — — —
FCF Margin Trend 6.16 -98.11 -106.07 -55.61 31.36 52.26 66.94 48.41 -130.39 -77.87 -82.80 -134.68 -456.09 -394.97 -272.31 -114438.78 -114159.55 -319221.03 — — —
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.04 0.71 0.68 0.55 0.66 0.77 0.79 1.03 0.82 0.92 0.93 0.92 0.98 0.97 1.06 237.98 193.16 245.79 245.77 1.20 1.195
FCF/OCF 1.01 1.01 1.00 1.00 1.00 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.00 1.00 1.00 1.00 1.00 1.002
FCF/Net Income snapshot only 1.198
CapEx/Revenue 23.8% 69.4% 61.1% 22.3% 5.0% 10.0% 12.4% 6.0% 56.9% 0.0% 36.5% 28.2% 82.1% 2.2% 1.8% 32.6% 69.8% 3.9% — — —
CapEx/Depreciation snapshot only 0.065
Accruals Ratio 0.02 -0.17 -0.19 -0.30 -0.25 -0.15 -0.14 0.01 -0.10 -0.04 -0.04 -0.05 -0.01 -0.02 0.05 205.88 235.44 221.80 303.38 0.22 0.224
Sloan Accruals snapshot only -0.408
Cash Flow Adequacy snapshot only -412.394
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -1.6% -1.7% -0.9% -2.5% -2.4% -20.7% -25.3% -11.2% -9.8% -3.9% -3.3% -11.3% -15.2% -72.5% -72.1% -18.7% -32.0% -6.5% -44.2% -78.4% -78.36%
Total Shareholder Return -1.6% -1.7% -0.9% -2.5% -2.4% -20.7% -25.3% -11.2% -9.8% -3.9% -3.3% -11.3% -15.2% -72.5% -72.1% -18.7% -32.0% -6.5% -44.2% -78.4% -78.36%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
EBIT Margin -33.17 -169.76 -202.42 -165.98 -29.95 -26.93 -23.59 -17.38 -191.24 -160.93 -172.72 -204.22 -552.65 -491.73 -340.80 -481.31 -592.82 -1300.00 — — —
Asset Turnover 0.01 0.00 0.00 0.00 0.02 0.02 0.03 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 1.25 1.20 1.17 1.30 1.29 1.36 1.28 1.48 1.45 1.53 1.35 1.38 1.42 1.53 1.49 1.61 2.68 2.02 2.39 3.58 3.575
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.05 $-1.44 $-1.50 $-1.51 $-1.33 $-13.08 $-11.21 $-7.65 $-7.35 $-5.93 $-5.36 $-4.47 $-4.01 $-3.95 $-3.55 $-2.26 $-2.07 $-0.18 $-1.23 $-0.83 $-0.83
Book Value/Share $2.16 $1.90 $1.62 $1.27 $1.07 $10.40 $9.25 $7.69 $6.17 $5.15 $4.05 $3.56 $2.61 $2.52 $1.89 $0.73 $-0.15 $0.05 $0.09 $0.05 $0.05
Tangible Book/Share $2.09 $1.84 $1.56 $1.21 $1.02 $9.80 $8.67 $7.21 $6.17 $5.15 $4.05 $3.56 $2.61 $2.52 $1.89 $0.73 $-0.15 $0.05 $0.09 $0.05 $0.05
Revenue/Share $0.03 $0.01 $0.01 $0.01 $0.04 $0.48 $0.47 $0.44 $0.04 $0.04 $0.03 $0.02 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-1.10 $-1.03 $-1.02 $-0.83 $-0.87 $-10.06 $-8.93 $-7.87 $-6.03 $-5.46 $-4.99 $-4.14 $-3.94 $-3.85 $-3.78 $-537.87 $-400.23 $-44.53 $-302.08 $-0.99 $-0.99
OCF/Share $-1.09 $-1.03 $-1.03 $-0.84 $-0.87 $-10.11 $-8.87 $-7.84 $-6.01 $-5.46 $-5.00 $-4.13 $-3.93 $-3.83 $-3.76 $-537.87 $-400.23 $-44.53 $-302.07 $-0.99 $-0.99
Cash/Share $1.88 $1.91 $1.65 $1.48 $1.13 $11.83 $10.39 $8.85 $7.48 $6.37 $4.53 $4.06 $3.01 $3.47 $2.52 $1.22 $0.97 $0.12 $0.55 $0.45 $0.45
EBITDA/Share $-1.00 $-1.41 $-1.46 $-1.47 $-1.30 $-12.67 $-10.91 $-7.36 $-7.09 $-5.72 $-5.18 $-4.34 $-3.90 $-3.83 $-3.44 $-2.18 $-2.01 $-0.17 $-1.19 $-0.79 $-0.79
Debt/Share $0.16 $0.16 $0.15 $0.14 $0.13 $1.50 $1.45 $1.40 $1.33 $1.33 $0.58 $0.48 $0.44 $0.44 $0.41 $0.27 $0.19 $0.02 $0.13 $0.10 $0.10
Net Debt/Share $-1.72 $-1.75 $-1.49 $-1.34 $-1.00 $-10.33 $-8.94 $-7.45 $-6.15 $-5.05 $-3.96 $-3.58 $-2.57 $-3.03 $-2.10 $-0.95 $-0.78 $-0.10 $-0.42 $-0.35 $-0.35
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -55.490
Altman Z-Prime snapshot only -128.588
Piotroski F-Score 3 3 1 1 2 3 4 4 4 4 4 4 3 3 1 1 1 1 0 1 1
Beneish M-Score -2.66 -1.65 -4.16 -3.19 22.47 2.50 -4.26 -2.54 -4.16 2.62 — -4.70 — -3.32 — — — — — — —
Ohlson O-Score snapshot only 3.770
ROIC (Greenblatt) snapshot only -8.92%
Net-Net WC snapshot only $-0.06
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B
Credit Score 59.35 60.99 61.93 63.91 64.09 33.43 33.17 33.10 32.09 31.88 33.52 32.91 32.81 32.06 42.23 39.70 20.00 36.29 32.02 27.56 27.555
Credit Grade snapshot only 15
Credit Trend snapshot only -12.148
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 18
Sector Credit Rank snapshot only 17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms